Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Outterson

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Health Affairs (Project Hope)|January 9, 2008
Market-based licensing for HPV vaccines in developing countriesKevin Outterson, Aaron S Kesselheim
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 6, 2015
What Will It Take to Address the Global Threat of Antibiotic Resistance?Steven J Hoffman, Kevin Outterson
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 6, 2015
INTRODUCTION: What Will It Take to Address the Global Threat of Antibiotic Resistance?Steven J Hoffman, Kevin Outterson
Health Affairs (Project Hope)|August 1, 2009
How Medicare could get better prices on prescription drugsKevin Outterson, Aaron S Kesselheim
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2020
Antibacterial R&D at a Crossroads: We've Pushed as Hard as We Can … Now We Need to Start Pulling!John H Rex, Kevin Outterson
Translational Research : the Journal of Laboratory and Clinical Medicine|March 14, 2020
Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercializationKevin Outterson, John H Rex
The Lancet. Infectious Diseases|April 3, 2016
Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approachJohn H Rex, Kevin Outterson
Applied Health Economics and Health Policy|February 11, 2023
Global Pull Incentives for Better Antibacterials: The UK Leads the WayKevin Outterson, John H Rex
The Milbank Quarterly|August 28, 2025
Policy Options for Antimicrobial Resistance: Exploring Lessons From Environmental GovernanceIsaac Weldon, Kathleen Liddell, Kevin Outterson
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 8, 2023
<b>Introduction:</b> AMR Belongs in the Pandemic InstrumentSusan Rogers Van Katwyk, Kevin Outterson
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Health Affairs (Project Hope)|January 9, 2008
Market-based licensing for HPV vaccines in developing countriesKevin Outterson, Aaron S Kesselheim
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 6, 2015
What Will It Take to Address the Global Threat of Antibiotic Resistance?Steven J Hoffman, Kevin Outterson
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 6, 2015
INTRODUCTION: What Will It Take to Address the Global Threat of Antibiotic Resistance?Steven J Hoffman, Kevin Outterson
Health Affairs (Project Hope)|August 1, 2009
How Medicare could get better prices on prescription drugsKevin Outterson, Aaron S Kesselheim
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2020
Antibacterial R&D at a Crossroads: We've Pushed as Hard as We Can … Now We Need to Start Pulling!John H Rex, Kevin Outterson
Translational Research : the Journal of Laboratory and Clinical Medicine|March 14, 2020
Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercializationKevin Outterson, John H Rex
The Lancet. Infectious Diseases|April 3, 2016
Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approachJohn H Rex, Kevin Outterson
Applied Health Economics and Health Policy|February 11, 2023
Global Pull Incentives for Better Antibacterials: The UK Leads the WayKevin Outterson, John H Rex
The Milbank Quarterly|August 28, 2025
Policy Options for Antimicrobial Resistance: Exploring Lessons From Environmental GovernanceIsaac Weldon, Kathleen Liddell, Kevin Outterson
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 8, 2023
<b>Introduction:</b> AMR Belongs in the Pandemic InstrumentSusan Rogers Van Katwyk, Kevin Outterson
Pageof 8